Sunday, October 4, 2015

Daniel Hoffman

A 5,455 percent price increase? Expect more of it

Thursday, September 24, 2015, 12:37 PM
After Pope Francis's visit to the U.S., possibly the biggest news item this week has been the depraved price increase that Turing Pharmaceuticals posted for its drug, Daraprim. Although the 5,455 percent that Turing hiked Daraprim's price is astounding, the absolute daily price is less than that of... Read more

Will high drug prices boomerang on pharma?

Monday, September 14, 2015, 3:10 PM
As surely as the seasons change and the tides rise, pharma will continue raising the prices of medications wherever and whenever it can. In one example from last week, the non-profit Institute for Clinical and Economic Review (ICER) found that the new class of cholesterol medications, the PCSK-9s... Read more

Excuses for price gouging on drugs don't hold water

Friday, September 4, 2015, 11:06 AM
The pharmaceutical industry is feeling rising heat from all directions as a result of its excessive price increases that reflect a contempt for consumers and the nation's economy. In response, pharma has been mobilizing its defenders in the media and academia to deploy the industry's standard mixture... Read more

Just how bad are drug price increases?

Thursday, September 3, 2015, 10:33 AM
The magnitude of the problem is astonishing. Although expensive specialty drugs are only 2-3 percent of all prescriptions, they account for approximately one-third of all medication costs. According to a report late last year by IMS, a market data supplier for the pharmaceutical industry, the costs... Read more

How much to cut drug prices?

Monday, August 31, 2015, 5:30 AM
On August 20, the Kaiser Family Foundation published the latest results from its poll that tracks health care opinions among American consumers. The pollsters found that only slightly more than four in 10 respondents (42 percent) have a positive view of pharma companies. That ranks the pharma industry... Read more

Proposals to make drug pricing more transparent

Monday, August 24, 2015, 5:30 AM
Americans are starting to feel the pinch from high drug prices. In a survey recently reported by Consumer Reports, one-third of Americans said they paid an average of $39 above the usual cost for their latest prescription. One in ten said they paid $100 or more out-of-pocket. Forty per cent of people... Read more

Follow Up: Tips to cut your prescription costs

Monday, August 17, 2015, 12:40 PM
After an excerpt from last week's post appeared in the Inquirer's Sunday print edition, a number of people called and wrote to ask where they could find a Canadian pharmacy to save some money on prescriptions. I told them that as someone who is not a health care practitioner, I cannot recommend any... Read more

7 tips to cut your prescription costs

Monday, August 10, 2015, 12:26 PM
Last year the U.S. sustained the biggest increase in prescription drug spending since 2003, according to a report published this spring by pharmacy benefit manager, Express Scripts. Hefty increases in drug costs are likely to continue as pharma prepares to launch new drug classes such as PCSK-9's... Read more

Pharma stiffs suppliers on invoice payment times: accounting or crime?

Monday, August 3, 2015, 9:20 AM
Any supplier of services to the pharmaceutical industry is acutely aware that the drug companies now take far longer to pay invoices. In many other ways, pharma's onerous payment terms have imposed serious burdens on those vastly smaller suppliers. This seemingly humdrum matter of invoice payment policy... Read more

Pharma distorts the facts to keep Medicare from negotiating drug prices

Monday, July 27, 2015, 10:40 AM
In 1967, Richard S. Harris wrote a four-part series for The New Yorker, describing how Medicare came to be enacted. The leading opponent of that legislation was the American Medical Association. The AMA's central argument against this valuable piece of legislation was its contention that government-supported... Read more
About this blog

Check Up is a blog for savvy health consumers, covering the latest developments, discoveries, and debates from the Philadelphia area and beyond.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Charlotte Sutton Health and Science Editor, Philadelphia Inquirer
Tom Avril Inquirer Staff Writer, heart health and general science
Justin D'Ancona
Stacey Burling Inquirer Staff Writer, neuroscience and aging
Marie McCullough Inquirer Staff Writer, cancer and women's health
Don Sapatkin Inquirer Staff Writer, public health, infectious diseases and substance abuse
David Becker, M.D. Board certified cardiologist, Chestnut Hill Temple Cardiology
Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on
letter icon Newsletter